Drug reverses brain deficits of Alzheimer's in animal model
Tuesday, August 5, 2014 - 15:30
in Health & Medicine
Researchers have discovered a new drug compound that reverses the brain deficits of Alzheimer's disease in an animal model. The compound, TC-2153, inhibits the negative effects of a protein called STtriatal-Enriched tyrosine Phosphatase (STEP), which is key to regulating learning and memory.